Could the secret to protecting our brains be hidden in marine algae?
In short: As neurodegenerative diseases like Alzheimer's and Parkinson's rise globally, scientists are looking toward the ocean. Beyond their role in food and industry, certain marine metabolites show remarkable potential to defend neurons against the very mechanisms that drive brain decay.
Neurodegenerative disorders, including Alzheimer’s and Parkinson’s, are characterized by the region-specific loss of neurons. While the exact causes of these diseases remain unknown, they share several common pathological drivers: oxidative stress, neuroinflammation, mitochondrial dysfunction, and the failure of protein clearance systems. Similarly, brain injuries from trauma or ischemia often trigger secondary damage through these same pathways. These degenerative changes can occur during both pathological and physiological aging. Furthermore, the complications following cerebral ischemia and various brain injuries often follow these same destructive pathways.
Marine algae are emerging as a promising frontier for drug discovery because they produce unique bioactive metabolites. Unlike many synthetic drugs that can cause significant side effects, naturally-derived compounds are often better tolerated by the human body. Preclinical studies have demonstrated that algal compounds can provide neuroprotection against various neurotoxic stressors, such as glutamate, amyloid β, and oxygen or glucose deprivation. These marine-derived substances may also assist with cholesterol homeostasis and protein clearance. Additionally, researchers are investigating their anti-amyloidogenic and anti-inflammatory properties to combat neuroinflammation.
The therapeutic potential of these organisms is already moving toward clinical reality. A notable recent milestone is the approval of sodium oligomannate, an algal oligosaccharide, for treating Alzheimer’s disease. This advancement highlights a growing interest in using algal metabolites to target disease pathogenesis directly, rather than merely alleviating symptoms as many current therapies do. This success provides a new way forward for marine algae-based drug discovery. Scientists are now proposing rational strategies to use computer-aided drug discovery to find more of these metabolites.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Can We Keep Neurons Active…with Algae?
- Also: Neuroprotective Potentials of Marine Algae and Their Bioactive Metabolites: Pharmacological Insights and Therapeutic Advances
To cite this card, link to https://intellectplus.co.uk/app/science-can-we-keep-neurons-active-with-algae.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Science · Latest · A–Z · All topics
